Atlas Trials

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

Clinical trial NCT05617820 · COMPLETED

Trial details

NCT number
NCT05617820
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dyspareunia
Start date
2022-11-15
Primary completion
2024-03-15
Enrollment
1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.